Cargando…

Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating miR-17-5p

BACKGROUND: Targeting the long non-coding RNAs (LncRNAs)-microRNAs (miRNAs)-mRNA competing endogenous RNA (ceRNA) networks has been proved as an effective strategy to treat multiple cancers, including oral squamous cell carcinoma (OSCC). Based on this, the present study identified a novel LncRNA SNH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qiuling, Han, Jingxin, Xu, Pu, Jian, Xinchun, Huang, Xieshan, Liu, Deyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910113/ https://www.ncbi.nlm.nih.gov/pubmed/33654431 http://dx.doi.org/10.2147/CMAR.S298236

Ejemplares similares

LncRNA-SNHG16 Silencing Inhibits Prostate Carcinoma Cell Growth, Downregulate GLUT1 Expression and Reduce Glucose Uptake
por: Shao, Mingfeng, et al.
Publicado: (2020)

Aberrant methylation-mediated downregulation of lncRNA CCND2 AS1 promotes cell proliferation in cervical cancer
por: Zhao, Chengcheng, et al.
Publicado: (2020)

pncCCND1_B Engages an Inhibitory Protein Network to Downregulate CCND1 Expression upon DNA Damage
por: Palombo, Ramona, et al.
Publicado: (2022)

Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
por: Adélaide, J., et al.
Publicado: (1995)

Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas
por: Xu, Jia, et al.
Publicado: (2018)

Prognostic and Clinicopathological Significance of CCND1/Cyclin D1 Upregulation in Melanomas: A Systematic Review and Comprehensive Meta-Analysis
por: González-Ruiz, Lucía, et al.
Publicado: (2021)

Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia
por: Zhou, Hao, et al.
Publicado: (2023)

LncRNA SNHG6 Silencing Could Arrest Progression of High Grade Colorectal Cancers
por: Jafari-Oliayi, Amin, et al.
Publicado: (2022)

Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters
por: Mohammedi, Latifa, et al.
Publicado: (2019)

Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines
por: Li, Hang, et al.
Publicado: (2019)

lncRNA SNHG17 is Downregulated in Gestational Diabetes Mellitus (GDM) and Has Predictive Values
por: Li, Jingjun, et al.
Publicado: (2021)

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.
por: Betticher, D. C., et al.
Publicado: (1996)

Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma
por: Krieger, Sophie, et al.
Publicado: (2006)

LncRNA SNHG9 is downregulated in osteoarthritis and inhibits chondrocyte apoptosis by downregulating miR-34a through methylation
por: Zhang, Hongfei, et al.
Publicado: (2020)

LncRNA NR2F2-AS1 Silencing Induces Cell Cycle Arrest in G0/G1 Phase via Downregulating Cyclin D1 in Colorectal Cancer
por: Liu, Jianfeng, et al.
Publicado: (2020)

lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer
por: Yu, Gan, et al.
Publicado: (2019)

LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer
por: Zhang, Mingkun, et al.
Publicado: (2021)

LncRNA SNHG10 is downregulated in non-small cell lung cancer and predicts poor survival
por: Liang, Meng, et al.
Publicado: (2020)

Cyclin D1 + large B-cell lymphoma with altered CCND1 and BCL-6 rearrangements: a diagnostic challenge
por: Gao, Da, et al.
Publicado: (2019)

LncRNA SNHG1: role in tumorigenesis of multiple human cancers
por: Zeng, Huang, et al.
Publicado: (2023)

LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
por: Fei, Fan, et al.
Publicado: (2018)

Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers
por: Minarikova, Petra, et al.
Publicado: (2016)

Novel RNA-binding activity of MYF5 enhances Ccnd1/Cyclin D1 mRNA translation during myogenesis
por: Panda, Amaresh C., et al.
Publicado: (2016)

Association Between Polymorphism rs678653 in Human Cyclin D1 Gene (CCND1) and Susceptibility to Cancer: A Meta-Analysis
por: Dai, Xichao, et al.
Publicado: (2016)

MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1)
por: Zhu, Yong, et al.
Publicado: (2018)

Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis
por: Zhang, Yafei, et al.
Publicado: (2016)

G870A Polymorphic Variants of CCND1 Gene and Cyclin D1 Protein Expression as Prognostic Markers in Laryngeal Lesions
por: Kowalczyk, Magdalena Marianna, et al.
Publicado: (2022)

Upregulation of lncRNA SNHG1 is associated with metastasis and poor prognosis in cancers: A meta-analysis
por: Yu, Jing, et al.
Publicado: (2019)

The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features
por: Wang, Lu, et al.
Publicado: (2016)

Prognostic Significance of Cyclins A2, B1, D1, and E1 and CCND1 Numerical Aberrations in Oral Squamous Cell Carcinomas
por: Monteiro, Luís Silva, et al.
Publicado: (2018)

Retraction: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
Publicado: (2021)

The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion
por: Kamarajan, Pachiyappan, et al.
Publicado: (2010)

lncRNA FLVCR-AS1 promotes osteosarcoma growth by targeting miR381-3p/CCND1
por: Yang, Guang, et al.
Publicado: (2020)

Expression of Concern: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
Publicado: (2020)

Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1
por: Wang, Shi-shuo, et al.
Publicado: (2020)

The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis
por: Dong, Bingzi, et al.
Publicado: (2019)

LncRNA SNHG1 was down-regulated after menopause and participates in postmenopausal osteoporosis
por: Huang, Shuaihao, et al.
Publicado: (2019)

Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter
por: Chen, Dian-gang, et al.
Publicado: (2017)

LncRNA CASC15 upregulates cyclin D1 by downregulating miR-365 in laryngeal squamous cell carcinoma to promote cell proliferation
por: Zhu, Minhui, et al.
Publicado: (2022)

Silence of MCL-1 upstream signaling by shRNA abrogates multiple myeloma growth
por: Wang, Mengchang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5g52acog7v1qvf71l0otso2n6d